Australia markets open in 3 hours 23 minutes

Fisher & Paykel Healthcare Corporation Limited (FSPKF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
17.58+17.58 (0.00%)
At close: 04:00PM EDT

Fisher & Paykel Healthcare Corporation Limited

15 Maurice Paykel Place
East Tamaki
Auckland 2013
New Zealand
64 9 574 0100
https://www.fphcare.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees6,978

Key executives

NameTitlePayExercisedYear born
Mr. Lewis G. GradonMD, CEO & Executive Director1.73MN/A1961
Ms. Lyndal YorkChief Financial OfficerN/AN/AN/A
Mr. Andy NiccolCOO & GM of Respiratory HumidificationN/AN/AN/A
Dr. Andrew SomervellVice President of Products & TechnologyN/AN/AN/A
Hayden BrownHead of Capital Markets & Investor RelationsN/AN/AN/A
Raelene LeonardCompany Secretary & General CounselN/AN/AN/A
Daniel AdolphSenior Communications & Investor Relations ManagerN/AN/AN/A
Mr. Justin CallahanVP of Sales & Marketing and President of North America & EuropeN/AN/AN/A
Ms. Nicola TalbotVice President of Human ResourcesN/AN/AN/A
Mr. Jonathan RhodesVice President of Supply Chain, Facilities & SustainabilityN/AN/AN/A
Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Corporate governance

Fisher & Paykel Healthcare Corporation Limited’s ISS governance QualityScore as of 1 July 2024 is 6. The pillar scores are Audit: 5; Board: 5; Shareholder rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.